Skip to content
OpenCapital
Get started

First Tracks Biotherapeutics, Inc. Ordinary Shares TRAX Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoY
SimplifiedDetailed
FY'25
Cash and cash equivalents
$238.2M—
Short-term investments
$73.44M—
Total current assets
$316.4M—
Property and equipment, net
$1.37M—
Total assets
$330.55M—
Accounts payable
$3.11M—
Total current liabilities
$31.02M—
Total stockholders' equity
$287.49M-26.6%
Total liabilities and stockholders' equity
$330.55M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are First Tracks Biotherapeutics, Inc. Ordinary Shares's total assets?
First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) holds $290.6M in total assets.
How much cash does First Tracks Biotherapeutics, Inc. Ordinary Shares have?
First Tracks Biotherapeutics, Inc. Ordinary Shares holds $248.5M in cash and equivalents.
Can First Tracks Biotherapeutics, Inc. Ordinary Shares cover its short-term obligations?
Its current ratio is 8.74 — current assets exceed current liabilities.
Where does First Tracks Biotherapeutics, Inc. Ordinary Shares's balance sheet data come from?
Every line is extracted from First Tracks Biotherapeutics, Inc. Ordinary Shares's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.